Dafna-Capital-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "ASND",
  "EWTX",
  "ALKS",
  "RVMD",
  "ORIC",
  "GLPG",
  "BCAX",
  "BCYC",
  "ATXS",
  "ALLO",
  "RCUS",
  "GPCR",
  "IMTX",
  "TSHA",
  "ACET",
  "STOK",
  "LRMR",
  "MLYS",
  "ADCT",
  "SNDX",
  "KROS",
  "NGNE",
  "SAGE",
  "TSVT",
  "ALEC",
  "APRE",
  "BWAY",
  "PHGE",
  "AUTL",
  "NBIX",
  "KRRO",
  "KALV",
  "LXEO",
  "LCTX",
  "MDWD",
  null,
  "PVLA",
  "PRQR",
  "SPRO",
  "TELA",
  "STXS",
  "TNYA",
  "STRO",
  null,
  "IFRX",
  "PODD",
  "IDYA",
  null,
  "SPRY",
  null,
  "ATRC",
  "AQST",
  "RGLS",
  "ARAY",
  "GOSS",
  "ALGN",
  "CGEN",
  "CMPS",
  "ERAS",
  "ITOS",
  "INGN",
  "KURA",
  "URGN",
  "VKTX",
  "VYNE",
  "XENE",
  "FHTX",
  "BHVN",
  "TNDM",
  "IMVT",
  null,
  "AXGN",
  "BDTX",
  "BCRX",
  "BNTX",
  "BPMC",
  "CRDF",
  "IPSC",
  "DAWN",
  "CYTK",
  "DNLI",
  "DXCM"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 83
Total Value: 352661806
Accession Number: 0001389933-25-000002
Form Type: 13F-HR
CIK: dafna-capital-management
Manager Name: Dafna-Capital-Management

Data Enrichment

94% identified

78 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

83 positions • $352.7M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 4 of 5

Sort by:

Autolus Therapeutics plc

AUTL|05280R100

Shares:586.7K

Value:$909.3K

% of Portfolio:0.3% ($909.3K/$352.7M)

Sage Therapeutics, Inc.

SAGE|78667J108

Shares:108.2K

Value:$860.2K

% of Portfolio:0.2% ($860.2K/$352.7M)

Korro Bio, Inc.

KRRO|500946108

Shares:47.1K

Value:$819.8K

% of Portfolio:0.2% ($819.8K/$352.7M)

Century Therapeutics, Inc.

IPSC|15673T100

Shares:1.7M

Value:$811.2K

% of Portfolio:0.2% ($811.2K/$352.7M)

Larimar Therapeutics, Inc.

LRMR|517125100

Shares:371.4K

Value:$798.6K

% of Portfolio:0.2% ($798.6K/$352.7M)

M8001Q126

Shares:291.3K

Value:$789.4K

% of Portfolio:0.2% ($789.4K/$352.7M)

Taysha Gene Therapies, Inc.

TSHA|877619106

Shares:522.5K

Value:$726.3K

% of Portfolio:0.2% ($726.3K/$352.7M)

BICYCLE THERAPEUTICS PLC

BCYC|088786108

Shares:80.8K

Value:$686.0K

% of Portfolio:0.2% ($686.0K/$352.7M)

Neurogene Inc.

NGNE|64135M105

Shares:51.5K

Value:$603.1K

% of Portfolio:0.2% ($603.1K/$352.7M)

Cardiff Oncology, Inc.

CRDF|14147L108

Shares:150.0K

Value:$471.0K

% of Portfolio:0.1% ($471.0K/$352.7M)

Erasca, Inc.

ERAS|29479A108

Shares:340.0K

Value:$465.8K

% of Portfolio:0.1% ($465.8K/$352.7M)

InflaRx N.V.

IFRX|N44821101

Shares:450.0K

Value:$459.0K

% of Portfolio:0.1% ($459.0K/$352.7M)

Adicet Bio, Inc.

ACET|007002108

Shares:600.0K

Value:$453.0K

% of Portfolio:0.1% ($453.0K/$352.7M)

Aquestive Therapeutics, Inc.

AQST|03843E104

Shares:142.0K

Value:$411.8K

% of Portfolio:0.1% ($411.8K/$352.7M)

COMPUGEN LTD

CGEN|M25722105

Shares:272.4K

Value:$397.7K

% of Portfolio:0.1% ($397.7K/$352.7M)

ADC Therapeutics SA

ADCT|H0036K147

Shares:224.1K

Value:$316.0K

% of Portfolio:0.1% ($316.0K/$352.7M)

SUTRO BIOPHARMA, INC.

STRO|869367102

Shares:437.1K

Value:$284.4K

% of Portfolio:0.1% ($284.4K/$352.7M)

Aprea Therapeutics, Inc.

APRE|03836J201

Shares:137.2K

Value:$279.8K

% of Portfolio:0.1% ($279.8K/$352.7M)

BiomX Inc.

PHGE|09090D301

Shares:401.1K

Value:$222.9K

% of Portfolio:0.1% ($222.9K/$352.7M)

64157F103

Shares:38.0K

Value:$221.9K

% of Portfolio:0.1% ($221.9K/$352.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Autolus Therapeutics plc(AUTLcusip05280R100)	586.7K	QoQ 0.00% (-0) YoY +170.76% (-370.0K)	All Managers (Combined)	$909.3K	0.3% ($909.3K/$352.7M)	QoQ -34.04% (-$469.3K) YoY -34.21% (-$473.0K)
Sage Therapeutics, Inc.(SAGEcusip78667J108)	108.2K	QoQ 0.00% (+0) YoY NEW(+108.2K)	All Managers (Combined)	$860.2K	0.2% ($860.2K/$352.7M)	QoQ +46.40% (+$272.7K) YoY NEW(+$860.2K)
Korro Bio, Inc.(KRROcusip500946108)	47.1K	QoQ NEW(+47.1K) YoY NEW(+47.1K)	All Managers (Combined)	$819.8K	0.2% ($819.8K/$352.7M)	QoQ NEW(+$819.8K) YoY NEW(+$819.8K)
Century Therapeutics, Inc.(IPSCcusip15673T100)	1.7M	QoQ 0.00% (-0) YoY +30.35% (-396.8K)	All Managers (Combined)	$811.2K	0.2% ($811.2K/$352.7M)	QoQ -52.87% (-$910.1K) YoY -85.15% (-$4.7M)
Larimar Therapeutics, Inc.(LRMRcusip517125100)	371.4K	QoQ 0.00% (-0) YoY -43.41% (-284.9K)	All Managers (Combined)	$798.6K	0.2% ($798.6K/$352.7M)	QoQ -44.44% (-$638.9K) YoY -83.97% (-$4.2M)
(cusipM8001Q126)✕	291.3K	QoQ 0.00% (-0) YoY +57.06% (-105.8K)	All Managers (Combined)	$789.4K	0.2% ($789.4K/$352.7M)	QoQ -10.85% (-$96.1K) YoY -7.46% (-$63.7K)
Taysha Gene Therapies, Inc.(TSHAcusip877619106)	522.5K	QoQ 0.00% (-0) YoY NEW(+522.5K)	All Managers (Combined)	$726.3K	0.2% ($726.3K/$352.7M)	QoQ -19.65% (-$177.7K) YoY NEW(+$726.3K)
BICYCLE THERAPEUTICS PLC(BCYCcusip088786108)	80.8K	QoQ -33.11% (-40.0K) YoY -33.87% (-41.4K)	All Managers (Combined)	$686.0K	0.2% ($686.0K/$352.7M)	QoQ -59.43% (-$1.0M) YoY -77.45% (-$2.4M)
Neurogene Inc.(NGNEcusip64135M105)	51.5K	QoQ 0.00% (-0) YoY NEW(+51.5K)	All Managers (Combined)	$603.1K	0.2% ($603.1K/$352.7M)	QoQ -48.77% (-$574.2K) YoY NEW(+$603.1K)
Cardiff Oncology, Inc.(CRDFcusip14147L108)	150.0K	QoQ NEW(+150.0K) YoY NEW(+150.0K)	All Managers (Combined)	$471.0K	0.1% ($471.0K/$352.7M)	QoQ NEW(+$471.0K) YoY NEW(+$471.0K)
Erasca, Inc.(ERAScusip29479A108)	340.0K	QoQ NEW(+340.0K) YoY NEW(+340.0K)	All Managers (Combined)	$465.8K	0.1% ($465.8K/$352.7M)	QoQ NEW(+$465.8K) YoY NEW(+$465.8K)
InflaRx N.V.(IFRXcusipN44821101)	450.0K	QoQ NEW(+450.0K) YoY NEW(+450.0K)	All Managers (Combined)	$459.0K	0.1% ($459.0K/$352.7M)	QoQ NEW(+$459.0K) YoY NEW(+$459.0K)
Adicet Bio, Inc.(ACETcusip007002108)	600.0K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$453.0K	0.1% ($453.0K/$352.7M)	QoQ -21.51% (-$124.2K) YoY -67.87% (-$957.0K)
Aquestive Therapeutics, Inc.(AQSTcusip03843E104)	142.0K	QoQ +11.81% (-15.0K) YoY -71.60% (-358.0K)	All Managers (Combined)	$411.8K	0.1% ($411.8K/$352.7M)	QoQ -8.91% (-$40.3K) YoY -80.66% (-$1.7M)
COMPUGEN LTD(CGENcusipM25722105)	272.4K	QoQ -39.08% (-174.8K) YoY -36.68% (-157.8K)	All Managers (Combined)	$397.7K	0.1% ($397.7K/$352.7M)	QoQ -41.87% (-$286.5K) YoY -64.16% (-$712.2K)
ADC Therapeutics SA(ADCTcusipH0036K147)	224.1K	QoQ 0.00% (-0) YoY NEW(+224.1K)	All Managers (Combined)	$316.0K	0.1% ($316.0K/$352.7M)	QoQ -29.14% (-$130.0K) YoY NEW(+$316.0K)
SUTRO BIOPHARMA, INC.(STROcusip869367102)	437.1K	QoQ 0.00% (-0) YoY +30.83% (-103.0K)	All Managers (Combined)	$284.4K	0.1% ($284.4K/$352.7M)	QoQ -64.64% (-$519.9K) YoY -84.93% (-$1.6M)
Aprea Therapeutics, Inc.(APREcusip03836J201)	137.2K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$279.8K	0.1% ($279.8K/$352.7M)	QoQ -37.99% (-$171.5K) YoY -69.50% (-$637.9K)
BiomX Inc.(PHGEcusip09090D301)	401.1K	QoQ 0.00% (-0) YoY NEW(+401.1K)	All Managers (Combined)	$222.9K	0.1% ($222.9K/$352.7M)	QoQ -23.88% (-$70.0K) YoY NEW(+$222.9K)
(cusip64157F103)✕	38.0K	QoQ 0.00% (+0) YoY +35.71% (-10.0K)	All Managers (Combined)	$221.9K	0.1% ($221.9K/$352.7M)	QoQ +56.98% (+$80.6K) YoY -45.11% (-$182.4K)